Search alternatives:
cm decrease » _ decrease (Expand Search), c decreased (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 cm » 5 mm (Expand Search), 5 c (Expand Search)
cm decrease » _ decrease (Expand Search), c decreased (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 cm » 5 mm (Expand Search), 5 c (Expand Search)
-
19861
-
19862
-
19863
-
19864
S1 Dataset -
Published 2023“…Tβ4 alleviated oxidative damage by reducing MDA, LDH and ROS and increasing SOD and GSH-PX in Aβ-treated SH-SY5Y cells. We found that Tβ4 inhibit ERK/p38 MAPK pathway and intensify the expression of 5-HTR1A. …”
-
19865
Image_5_Breathing Abnormalities During Sleep and Wakefulness in Rett Syndrome: Clinical Relevance and Paradoxical Relationship With Circulating Pro-oxidant Markers.pdf
Published 2022“…</p>Methods<p>Female patients with a clinical diagnosis of typical RTT (n = 66), MECP2 gene mutation, and apneas were enrolled (mean age: 12.5 years). …”
-
19866
PCR Primers.
Published 2025“…Together, these results identify SLAMF5 as a key regulator of myeloid cell activation in neuroinflammation and suggest that it may represent a promising therapeutic target for autoimmune disorders such as MS.…”
-
19867
Suggested model.
Published 2025“…Together, these results identify SLAMF5 as a key regulator of myeloid cell activation in neuroinflammation and suggest that it may represent a promising therapeutic target for autoimmune disorders such as MS.…”
-
19868
Mouse antibodies.
Published 2025“…Together, these results identify SLAMF5 as a key regulator of myeloid cell activation in neuroinflammation and suggest that it may represent a promising therapeutic target for autoimmune disorders such as MS.…”
-
19869
Human antibodies.
Published 2025“…Together, these results identify SLAMF5 as a key regulator of myeloid cell activation in neuroinflammation and suggest that it may represent a promising therapeutic target for autoimmune disorders such as MS.…”
-
19870
-
19871
-
19872
Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers
Published 2019“…We found that the cell lines that were HMGA2-positive and/or HOXC9-negative have a reduced sensitivity to retinoids. Furthermore, the experiments revealed that the retinoid-sensitive cell lines showed a uniform pattern of change after treatment with both natural and sensitive retinoids: increased DDX39A and decreased PBX1 protein levels. …”
-
19873
-
19874
Table 1_The first photometric investigation of two short-period Algol-type eclipsing binaries: IW UMa and V367 Gem.pdf
Published 2025“…Using O−C analysis, we found that the period of IW UMa is likely increasing over the long term, superposed with cyclic variation. The period of V367 Gem is decreasing at a rate of dP/dt=−7.40(± 0.43)×10−8d⋅yr−1 on a long time scale.…”
-
19875
Cumulative release of Mn<sup>2+</sup> from MnO NPs over 24 hr after incubation in PBS pH 7.4 (dotted line), 20 mM citrate buffer pH 6.5 (dashed line), and 20 mM citrate buffer pH 5...
Published 2020“…Mn<sup>2+</sup> release increased with a decrease in pH. Time points are shown for 1, 2, 4, 8 and 24 hr. …”
-
19876
-
19877
-
19878
-
19879
-
19880